Consistent with the falling temperatures outside, investors are turning a cold shoulder to synthetic biology specialist Amyris (NASDAQ: AMRS) this week. As of the close of the trading session on Thursday, shares of Amyris have plunged 47% from their closing price of $14.09 last Friday.